References
- García Rodríguez LA, Duque A, Castellsague J, et al. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol. 1999;48(6):847–852.
- Choudhary NS, Kotecha H, Saraf N, et al. Terbinafine induced liver injury: a case report. J Clin Exp Hepatol. 2014;4(3):264–265.
- Kramer ON, Albrecht J. Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a critically appraised topic. Br J Dermatol. 2017;177(5):1279–1284.
- Understanding and Interpreting the National Hospital Ambulatory Medical Care Survey (NHAMCS): key questions and answers; 2020; [cited 2020 Apr 22]. Available from: https://www.cdc.gov/nchs/data/ahcd/annals_emerg_med_q_and_a_nchs_web_version.pdf
- Tapper EB, Saini SD, Sengupta N. Extensive testing or focused testing of patients with elevated liver enzymes. J Hepatol. 2017;66(2):313–319.
- Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123(4):1367–1384.